Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Pediatric Cancer Working Group Scientific Session: What's New? Rising Stars in Pediatric Oncology

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Fusion oncogenes co-opt developmental programs for rhabdomyosarcoma tumorigenesis
Genevieve C. Kendall
UT Southwestern Medical Ctr., Dallas, TX, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Implications of T cell variance in pediatric immunotherapy
David M Barrett
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Initiation of FN-RMS from endothelial progenitors
Catherine J Drummond
University of Otego, Dunedin, New Zealand
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Discovery and development of GPC2 as an immunotherapeutic target in neuroblastoma and other cancers
Kristopher R Bosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
Driver oncogenes specify differential requirements for GATOR2-mTORC1 activation in rhabdomyosarcoma
Amit J Sabnis
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 1:00 PM-3:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5